156 related articles for article (PubMed ID: 14997749)
1. [Clinical significance of TS and DPD activities in colorectal carcinoma as a predictive factor of UFT sensitivity].
Funahashi K; Koike J; Saito N; Miki T; Matsumoto H; Ryu M; Shiokawa H; Tokuyama T; Goto T; Teramoto T
Gan To Kagaku Ryoho; 2004 Feb; 31(2):189-93. PubMed ID: 14997749
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
Miyoshi T; Kondo K; Toba H; Yoshida M; Fujino H; Kenzaki K; Sakiyama S; Takehisa M; Tangoku A
Anticancer Res; 2007; 27(4C):2641-8. PubMed ID: 17695427
[TBL] [Abstract][Full Text] [Related]
3. [Thymidylate synthase and dihydropyrimidine dehydrogenase expression and histological effects of preoperative UFT in gastric cancer patients].
Uyama R; Yoshizawa Y; Tajiri T; Endo Y; Mitsuya T; Sanada Y
Gan To Kagaku Ryoho; 2006 May; 33(5):625-9. PubMed ID: 16685161
[TBL] [Abstract][Full Text] [Related]
4. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity.
Miyoshi T; Kondo K; Fujino H; Takahashi Y; Sawada N; Sakiyama S; Tsuyuguchi M; Kimura S; Sumitomo M; Monden Y
Anticancer Res; 2005; 25(2A):923-30. PubMed ID: 15868929
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.
Nakagawa T; Tanaka F; Takata T; Matsuoka K; Miyahara R; Otake Y; Yanagihara K; Fukushimab M; Wada H
J Surg Oncol; 2002 Oct; 81(2):87-92. PubMed ID: 12355409
[TBL] [Abstract][Full Text] [Related]
7. Do the expression of CD44, apoptosis and thymidylate synthase inhibition rate correlate with the efficacy of chemotherapy in colorectal cancer?
Tachikawa D; Arima S; Futami K; Iwashita A
Anticancer Res; 2000; 20(1C):595-600. PubMed ID: 10769701
[TBL] [Abstract][Full Text] [Related]
8. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
Ishida H; Yamada H; Shirakawa K; Nakada H; Ohsawa T; Takeuchi I; Okada N; Yokoyama M; Inokuma S; Suzuki T; Odaka A; Hoshino T; Murata N; Hashimoto D; Itoyama S; Mori T; Matsumoto Y; Miura T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1621-6. PubMed ID: 14619479
[TBL] [Abstract][Full Text] [Related]
9. Effects of UFT on thymidylate synthase and dihydropyrimidine dehydrogenase activities in lung cancer.
Miyamoto H; Morio A; Izumi H; Yamazaki A; Wang Z; Futagawa T; Sonobe S
Anticancer Res; 2003; 23(5b):4153-6. PubMed ID: 14666617
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between clinical pathologic factors and enzymatic activity of orotate Phosphoribosyl transferase (OPRT), Dihydropyrimidine dehydrogenase (DPD) and Thymidylate synthase (TS) in colorectal cancer].
Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Kanazawa Y; Shirakawa T; Ohkawa K; Koizumi M; Ohaki Y; Yamashita K; Tajiri T
Gan To Kagaku Ryoho; 2006 Jun; 33(6):789-93. PubMed ID: 16770098
[TBL] [Abstract][Full Text] [Related]
11. Tumor dihydropyrimidine dehydrogenase activity in advanced cervical carcinoma.
Nagai N; Shiroyama Y; Oshita T; Mukai K; Shigemasa K; Fujii T; Katsube Y; Matsubayashi S; Murakami T; Ohama K
Oncol Rep; 2002; 9(5):1033-40. PubMed ID: 12168069
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of two fluorouracil administration regimens for colorectal cancer.
Matsusaka S; Yamasaki H; Kitayama Y; Okada T; Maeda S
Oncol Rep; 2003; 10(1):109-13. PubMed ID: 12469154
[TBL] [Abstract][Full Text] [Related]
13. Dihydropyrimidine dehydrogenase activity during long-term adjuvant treatment with oral uracil and tegafur for colorectal cancer.
Sadahiro S; Suzuki T; Maeda Y; Ishikawa K; Tanaka Y; Yasuda S; Kamijo A; Makuuchi H; Murayama C
Chemotherapy; 2007; 53(6):442-5. PubMed ID: 17952005
[TBL] [Abstract][Full Text] [Related]
14. [Activities of thymidylate synthase and dihydropyrimidine dehydrogenase in patients with colorectal cancer].
Uehara M; Takahashi S; Takenaka A; Izumi H; Fujii K; Ikawa O; Miyata K; Iizuka R; Matsumura H; Kakihara N; Shono Y; Tsuchihashi H; Saisaka Y
Gan To Kagaku Ryoho; 2001 Dec; 28(13):2035-41. PubMed ID: 11791381
[TBL] [Abstract][Full Text] [Related]
15. Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy.
Toi M; Ikeda T; Akiyama F; Kurosumi M; Tsuda H; Sakamoto G; Abe O
Int J Oncol; 2007 Oct; 31(4):899-906. PubMed ID: 17786323
[TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase.
Nio Y; Iguchi C; Kodama H; Itakura M; Hashimoto K; Koike M; Toga T; Maruyama R; Fukushima M
Oncol Rep; 2007 Jan; 17(1):153-9. PubMed ID: 17143493
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between clinical pathophysiologic factors and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer].
Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Komiyama H; Okano M
Gan To Kagaku Ryoho; 2002 Mar; 29(3):413-20. PubMed ID: 11915731
[TBL] [Abstract][Full Text] [Related]
18. [Effects of neo-adjuvant chemotherapy with UFT (a combination of tegafur and uracil) on DNA-synthesizing enzyme activities in human colorectal carcinomas].
Sakamoto S; Kudo H; Kuwa K; Kawasaki T; Kasahara N; Okamoto R; Sagara T; Kawachi Y; Iwama T; Hirayama R
Nihon Gan Chiryo Gakkai Shi; 1989 Jan; 24(1):94-8. PubMed ID: 2500492
[TBL] [Abstract][Full Text] [Related]
19. Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers.
Baba H; Teramoto K; Kawamura T; Mori A; Imamura M; Arii S
Cancer Chemother Pharmacol; 2003 Dec; 52(6):469-76. PubMed ID: 13680162
[TBL] [Abstract][Full Text] [Related]
20. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]